The information presented at the 01/22/08 MATTO seminar:
are now available for download here.
MATTO is pleased to announce that it has finalized and approved a joint invention administration agreement (JIAA) format for use by all MATTO institutions.
The JIAA has been made possible by the efforts of Joyce Brinton working for MATTO, and the participation of the following MATTO institutions during its development: Beth Israel Deaconess Medical Center, Boston University, Brandeis University, Brigham & Women’s Hospital, Caritas St. Elizabeth’s Medical Center, Children’s Hospital, Dana Farber Cancer Institute, Harvard University, Joslin Diabetes Center, Massachusetts Eye and Ear Infirmary, Massachusetts General Hospital, Massachusetts Institute of Technology, Northeastern University, The Schepens Eye Research Institute, Tufts University and the University of Massachusetts.
The information presented at the 07/25/07 MATTO seminar is now available for download here:
Assuring Fair Access in Licensing of University Technology by Lita Nelsen, Director of the Technology Licensing Office at the Massachusetts Institute of Technology
Apple Pie, Motherhood and Global Health byAshley J. Stevens, Director of the Office of Technology Development, Boston University
AUTM members are strongly encouraged to act NOW to express concern to legislators about Patent Reform legislation currently in the House and Senate Judiciary Committees — mark-ups will occur before the July 4 recess. The proposed bills contain significant changes that would impact academic technology transfer.
Letters and e-mails from universities are needed to encourage legislators to hear from all stakeholders before voting. By working with your Federal Relations colleagues, AUTM members can have an impact. To learn how please visit http://www.autm.net/about/AboutAUTM_patentReform.cfm.
You also can click here to see a Draft Template Letter to express concerns to your legislators.
AUTM urges you to submit your letters before Thursday, June 21 when the Senate Judiciary Committee mark-up is scheduled. Please forward copies of any letters or e-mails you send to legislators on this topic to Vicki Loise at AUTM Headquarters at vloise@autm.net.
Special One-Day Registrations For Researchers
BIO is making available to researchers at MATTO Institutions a special one-day limited academic pass. These passes are $100 each and will give academics a day at BIO with access to all the panels and the exhibits but not the general sessions. This is a considerable discount on normal BIO registration fees. If you have researchers who would like to attend BIO for just one day please contact Julia Goldberg at jgoldberg@umassp.edu and the appropriate registration codes will be sent to you.
Biotechnology Entrepreneurship Boot Camp
BIO will hold a Biotechnology Entrepreneurship Boot Camp on May 6 and 7. Registration for this event is $245 in addition to convention registration. (Academics may use a one day limited pass ($100) as their convention registration to attend this event and BIO will allow them to attend both days of the Boot Camp for no additional charge.) For more information on the Boot Camp please visit http://bio2007.org/program/sessiondesc.asp?sid=940.
Other MTTC/MATTO involvement at BIO
Over a dozen MATTO members will form an “Academic Alley” in the Massachusetts Pavilion - please stop by and visit if you are in the exhibit hall. Many thanks to the MTC’s Life Sciences Collaborative for their sponsorship of this area.
Approximately 70 researchers from MATTO members will have posters on display in the Innovation Corridor. Through a sponsorship from Alnylam all of these researchers have been given a full conference pass. If you have researchers in the Innovation Corridor, please make sure that they take full benefit from these full passes and attend as much of the conference as possible.
MATTO Chair, Todd Keiller, will run a panel session on Monday, May 7 at 2:00 titled “Does Size Matter? Working with Differing Research Institutions”. Todd will be joined by Irene Abrams, Brandeis University; Reid Leonard, Ph.D., Merck Research Laboratories; Robert Pucciariello, Evolved Nanomaterial Sciences Inc.; and Frances Toneguzzo, Ph.D, Partners Healthcare.
